Skip to content
Screener

Total Revenue at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Stryker logo
StrykerSYK
$6.59B+9.4%
Alphatec Holdings logo
Alphatec HoldingsATEC
$192.11M+13.6%
Enovis logo
EnovisENOV
$582.78M+3.2%
OrthoPediatrics logo
OrthoPediatricsKIDS
$70.51M+15.4%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$23.03M-35.0%

Segments

By geography

See full
US$166.64M
IT$5.14M
FR$3M
GB$2.94M
DE$2.17M
BR$1.1M

By segment

See full
Global Spine$173.24M+2.0%
Global Limb Reconstruction$37.69M

Other financials

Income statement

See full
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$418.73M-18.1%
Enterprise value$552.6M-11.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(Unaudited, U.S. Dollars, in thousands, except per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net sales$210,933$203,121$407,641$396,767
Cost of sales61,22663,588118,388135,615
Gross profit149,707139,533289,253261,152
Sales, general, and administrative138,030136,493272,941269,474
Research and development15,94415,93431,26435,700
Acquisition-related amortization, impairment, and remeasurement (Note 11)3,8673,1097,61820,854
Operating loss(8,134)(16,003)(22,570)(64,876)
Interest expense, net(6,085)(3,950)(11,749)(8,456)

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s total revenue?
Orthofix Medical Inc. (OFIX) reported total revenue of $210.93M in Q2 2026.
How has Orthofix Medical Inc.'s total revenue changed year-over-year?
Orthofix Medical Inc.'s total revenue increased by 3.8% year-over-year, from $203.12M to $210.93M.
What is the long-term trend for Orthofix Medical Inc.'s total revenue?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s total revenue has grown at a 15.4% compound annual growth rate (CAGR), from $464.48M to $822.31M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Orthofix Medical Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude